(L-R): NSW Minister for Science, Innovation and Technology Alister Henskens, Myeloid Therapeutics CEO Dr Daniel Getts, Liberal candidate for Ryde Jordan Lane and Vice-Chancellor Professor S Bruce Dowton.
A $96 million RNA research and pilot manufacturing facility – the first of its kind in Australia – will be built at Macquarie University’s Wallumattagal Campus, the NSW Government has announced.
Vice-Chancellor Professor S Bruce Dowton joined NSW Minister for Science, Innovation and Technology Alister Henskens and project partners for the on-campus announcement on 20 February.
The groundbreaking facility will support the State’s capability to develop and manufacture RNA-based therapeutics locally. It is expected to conduct small-scale production of messenger RNA (mRNA), synthetic RNA (sRNA) and lipid nanoparticles (LNP) encapsulation at a scale which will enable clinical trials of new therapeutics.
“This facility has the potential to save lives by accelerating our biomedical research capabilities and boosting early-phase clinical trials to combat disease,” Mr Henskens said.
The facility will be operated by global therapeutics company Myeloid Therapeutics – co-founded by Australian researcher Dr Daniel Getts – following a competitive tender process.
In addition to leveraging Macquarie’s own world-class cell and gene therapy research expertise, the facility will also tap into the strong innovation ecosystem across NSW, including Macquarie Park, home to a host of medical- and health-related organisations and industrial and technology start-ups.
Professor Dowton, who represents the New South Wales Vice-Chancellors’ Committee in relation to the establishment of this facility, said the new facility will help create a thriving medical precinct in the Park.
“Macquarie’s researchers and clinicians are engaged in answering some of the most urgent medical questions of our time,” Professor Dowton said. “These are all areas where RNA research has tremendous potential, and we are proud to be the home of this important work going forward.”
The pilot facility will be built in the North Zone of the campus and is expected to be completed in 2025.
Watch 9News Sydney coverage of the RNA facility announcement
Back to homepage
Comments
We encourage active and constructive debate through our comments section, but please remain respectful. Your first and last name will be published alongside your comment.
Comments will not be pre-moderated but any comments deemed to be offensive, obscene, intimidating, discriminatory or defamatory will be removed and further action may be taken where such conduct breaches University policy or standards. Please keep in mind that This Week is a public site and comments should not contain information that is confidential or commercial in confidence.